Case Studies

GoApptiv required a structured fundraising process targeted towards investors with relevant healthcare and pharmaceutical exposure. Valence mapped and engaged venture capital firms and strategic investors whose investment focus aligned with the company’s long-term direction. The process was designed to maintain focused, high-quality investor discussions rather than broad market outreach.

Valence worked with management to reposition the company narrative around long-term scale, pharmaceutical portfolio depth, and healthcare distribution capabilities. Investor materials and discussions were rebuilt to present the business as a broader healthcare platform rather than a single operating business. This created stronger alignment during institutional discussions.

Alongside the capital raise, Valence analysed multiple pharmaceutical companies and brands being considered for acquisition. The evaluation process focused on portfolio fit, commercial relevance, and expansion potential. This supported the company’s broader inorganic growth strategy.

Valence supported the company across investor coordination, strategic discussions, acquisition evaluations, and ongoing execution support. The engagement continued beyond the initial fundraising process as GoApptiv expanded its pharmaceutical portfolio and strengthened its institutional investor network.